Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients

October 3, 2010 updated by: Rabin Medical Center
This is a single-center, prospective, randomized, comparative, double-blind controlled clinical study intended to establish 1) the optimal method of determining calorie requirements and 2) the optimal amount of protein supply in chronically ventilated patients.

Study Overview

Detailed Description

The study will be performed in a chronic ventilation department.

Enrolled patients will be randomly allocated to receive calories as dictated by:

The Harriss-Benedict formula (Group 1) or Indirect Calorimetry (Group 2)

After one week of admission to the hospital department and study enrollment we will review the first results of the study.

After seven days of hospitalization and study enrollment patients who have not been weaned from the ventilator, will be divided into three groups.

  1. Patients in the first group will receive caloric support calculated by the HARRISS BENEDICT equation and protein dose of 1.1 to 1.5 grams per kilogram weight.
  2. Patients in the second group will receive caloric support as measured by indirect calorimetry and will receive protein at 1.1 grams per kilogram weight.
  3. Patients in the third group will receive caloric support as measured by indirect calorimetry and will receive protein at a dose of 1.5 grams per kilogram weight.

Outcome of treatment results will be performed after one ,four and eight weeks:

  1. Length of hospitalization
  2. Weaning from Mechanical Ventilation
  3. Development and progression of pressure ulcers
  4. Infectious diseases incidence
  5. Amount of insulin needed for glucose control
  6. Length of mechanical ventilation
  7. Readmission to Intensive Care Unit
  8. Mortality rate

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 90 years (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Chronically Mechanical Ventilated Patients (more than 21 days of Mechanical Ventilation) by tracheostomy,
  • Between ages 65-90

Exclusion Criteria:

  • Patient over age 90 and younger the age of 65
  • PH level less than 7.3 due to metabolic causes.
  • A patient with blood albumin level less than 2.2 g / dl

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Group 1
Patients will be receive caloric support as dictated by Hariss-Benedict Formula (Group 1)
Four group 1-dose of caloric support will be calculated by Hariss-Benedict Formula measurement of Resting Energy Expenditure(REE).
ACTIVE_COMPARATOR: Group 2
Patients will be receive caloric support as dictated by Indirect Calorimetry (Group 2)
For group 2- dose of caloric support will be calculated by Indirect Calorimetric measurement of Resting Energy Expenditure(REE)
ACTIVE_COMPARATOR: Group 1A

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the first(Group 1A)group will receive caloric support calculated by the HARISS BENEDICT equation and protein dose of 1.1 to 1.5 grams per kilogram weight.

Patients in the first group(Group 1A) will receive caloric support calculated by the HARRISS BENEDICT equation and protein dose of 1.1 to 1.5 grams per kilogram weight.
ACTIVE_COMPARATOR: Group 2A

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the second group(Group 2A) will receive caloric support as measured by indirect calorimetry and will receive protein at 1.1 grams per kilogram weight.

Patients in the second group(Group 2A) will receive caloric support as measured by indirect calorimetry and will receive protein at 1.1 grams per kilogram weight.
ACTIVE_COMPARATOR: Group 3A

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the third group will receive caloric support as measured by indirect calorimetry and will receive protein at a dose of 1.5 grams per kilogram weight.

Patients in the third group (Group 3A) will receive caloric support as measured by indirect calorimetry and will receive protein at a dose of 1.5 grams per kilogram weight.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful weaning from ventilation
Time Frame: At one, four and eight weeks
Spontaneous breathing
At one, four and eight weeks
Length of hospital stay
Time Frame: At 8 weeks
Length of hospitalization, in days
At 8 weeks
Readmission to Intensive Care Unit
Time Frame: At four and eight weeks.
At four and eight weeks.
Readmission to Intensive Care Unit Mortality
Time Frame: At eight weeks
At eight weeks
Length of mechanical ventilation
Time Frame: At one, four and eight weeks
Length of mechanical ventilation in days/hours
At one, four and eight weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infectious diseases incidence
Time Frame: At one, four and eight weeks
At one, four and eight weeks
Development and progression of pressure ulcers
Time Frame: At one, four and eight weeks
At one, four and eight weeks
Checked daily insulin intake among different groups of patients
Time Frame: After one, four and eight weeks
Glucose Control
After one, four and eight weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Gregory Papirov, MD, Beit- Rivka Hospital, Petah-Tikva, Israel
  • Study Director: Pierre Singer, MD, Professor, ICU, Rabin Medical Center,Petah- Tikva, Israel
  • Study Director: Ludmila Zaidenberg, MD, Beit Rivka hospital, Petah- Tikva, Israel
  • Study Director: Milana Grinev, RN,Study Coordinator, ICU, Rabin Medical Center,Petah- Tikva, Israel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (ANTICIPATED)

September 1, 2012

Study Completion (ANTICIPATED)

November 1, 2012

Study Registration Dates

First Submitted

May 13, 2010

First Submitted That Met QC Criteria

June 10, 2010

First Posted (ESTIMATE)

June 11, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

October 5, 2010

Last Update Submitted That Met QC Criteria

October 3, 2010

Last Verified

January 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • 5668

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe